CREDIT SUISSE AG/ - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$57,000
+46.2%
19,406
+63.5%
0.00%
Q3 2019$39,000
+5.4%
11,868
-10.0%
0.00%
Q1 2019$37,000
-69.7%
13,187
-10.9%
0.00%
Q2 2018$122,00014,8050.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders